small intestinal bacterial overgrowth in patients with systemic sclerosis

Clicks: 236
ID: 147301
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Small intestinal bacterial overgrowth (SIBO) is common in patients with systemic sclerosis (SSc) yet often goes underrecognized in clinical practice. In patients with SSc, untreated SIBO may result in marked morbidity and possible mortality. The pathogenesis of SIBO is multifactorial and relates to immune dysregulation, vasculopathy, and dysmotility. This article reviews various diagnostic approaches and therapeutic options for SIBO. Treatment modalities mainly include prokinetics, probiotics, and antibiotics.
Reference Key
rawn2017indiansmall Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Saara Rawn;Natalia Pitman;Karen Beattie;Ava Bazzaz;Maggie Larche
Journal child abuse & neglect
Year 2017
DOI
DOI not found
URL
http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=167;epage=170;aulast=Rawn
Keywords
antibiotics probiotics scleroderma small bowel bacterial overgrowthdiseases of the musculoskeletal system

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.